Skip to main content

ChemoCentryx Awarded US Patent

Premium
ChemoCentryx has been awarded US Patent 7,396,653, “Cell migration assay.”
 
The inventors listed on the patent are Zheng Wei and Zhenhua Miao.
 
As stated in its abstract, the patent describes a modified cell migration assay allowing for the improved identification and discrimination of chemokine receptor antagonists from non-specific receptor blockers.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.